These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15729593)
1. Cancer pharmacogenomics: progress and obstacles toward the goal. Nishiyama M Int J Clin Oncol; 2005 Feb; 10(1):3-4. PubMed ID: 15729593 [No Abstract] [Full Text] [Related]
2. Cancer pharmacogenomics: international trends. Yamayoshi Y; Iida E; Tanigawara Y Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: from bedside to clinical practice. Marsh S; McLeod HL Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374 [TBL] [Abstract][Full Text] [Related]
4. Cancer pharmacogenomics: achievements in basic research. Nakajima M; Yokoi T Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595 [TBL] [Abstract][Full Text] [Related]
5. Progress in pharmacogenomics: bridging the gap from research to practice. Cascorbi I; Tyndale R Clin Pharmacol Ther; 2014 Mar; 95(3):231-5. PubMed ID: 24548984 [TBL] [Abstract][Full Text] [Related]
6. Perspective on the application of pharmacogenomics in the treatment of cancer. Wolf R Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511 [No Abstract] [Full Text] [Related]
7. Recent advances in the pharmacogenetics of cancer chemotherapy. Watters JW; McLeod HL Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358 [TBL] [Abstract][Full Text] [Related]
8. [Recent advances in pharmacogenomics in oncology]. Robert J; Bonnet J Bull Cancer; 2004 Jan; 91(1):19-28. PubMed ID: 14975802 [TBL] [Abstract][Full Text] [Related]
9. Special Section on Pharmacogenomics: recent advances and future directions. Mushiroda T; Giacomini KM; Kubo M J Hum Genet; 2013 Jun; 58(6):305. PubMed ID: 23797326 [No Abstract] [Full Text] [Related]
10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Yan L; Beckman R Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038 [TBL] [Abstract][Full Text] [Related]
11. The increasing complexity of mercaptopurine pharmacogenomics. Marsh S; Van Booven DJ Clin Pharmacol Ther; 2009 Feb; 85(2):139-41. PubMed ID: 19151640 [TBL] [Abstract][Full Text] [Related]
12. Somatic pharmacogenomics in cancer. Ikediobi ON Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398 [TBL] [Abstract][Full Text] [Related]
13. [Issues in cancer pharmacogenomics]. Korean J Hepatol; 2005; 11 Suppl 1():19-31. PubMed ID: 23570222 [No Abstract] [Full Text] [Related]
14. [Tasks and expectations for drug design based on pharmacogenomics]. Uyama Y Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):432-5. PubMed ID: 16463462 [No Abstract] [Full Text] [Related]
15. Pharmacogenomics: bench to bedside. Weinshilboum R; Wang L Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384 [TBL] [Abstract][Full Text] [Related]